Compugen Ltd.

Healthcare · Biotechnology · Israel

Last price 1.98 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 187.55M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe. The company’s pipeline consists of COM701, an immuno-oncology pipeline program with an anti-PVRIG antibody; COM902, a therapeutic anti-TIGIT antibody, are in Phase 1 clinical trials and have been evaluated for the treatment of solid tumors as a monotherapy and in combination of PVRIG/PD-1 and PVRIG/TIGIT, as well as PVRIG/PD-1/T...